11-102842716-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002422.5(MMP3):​c.306C>G​(p.Thr102Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0862 in 1,613,822 control chromosomes in the GnomAD database, including 6,341 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.087 ( 603 hom., cov: 30)
Exomes 𝑓: 0.086 ( 5738 hom. )

Consequence

MMP3
NM_002422.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.681

Publications

18 publications found
Variant links:
Genes affected
MMP3 (HGNC:7173): (matrix metallopeptidase 3) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. This gene encodes an enzyme which degrades fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans. The enzyme is thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-102842716-G-C is Benign according to our data. Variant chr11-102842716-G-C is described in ClinVar as Benign. ClinVar VariationId is 403096.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.681 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMP3NM_002422.5 linkc.306C>G p.Thr102Thr synonymous_variant Exon 2 of 10 ENST00000299855.10 NP_002413.1 P08254

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMP3ENST00000299855.10 linkc.306C>G p.Thr102Thr synonymous_variant Exon 2 of 10 1 NM_002422.5 ENSP00000299855.5 P08254
MMP3ENST00000524478.1 linkn.*148C>G non_coding_transcript_exon_variant Exon 2 of 4 4 ENSP00000435255.1 E9PKX2
MMP3ENST00000524478.1 linkn.*148C>G 3_prime_UTR_variant Exon 2 of 4 4 ENSP00000435255.1 E9PKX2

Frequencies

GnomAD3 genomes
AF:
0.0874
AC:
13286
AN:
152036
Hom.:
602
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0999
Gnomad AMI
AF:
0.145
Gnomad AMR
AF:
0.0707
Gnomad ASJ
AF:
0.134
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.0661
Gnomad FIN
AF:
0.0592
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.0924
Gnomad OTH
AF:
0.0855
GnomAD2 exomes
AF:
0.0760
AC:
19075
AN:
251098
AF XY:
0.0778
show subpopulations
Gnomad AFR exome
AF:
0.0992
Gnomad AMR exome
AF:
0.0474
Gnomad ASJ exome
AF:
0.137
Gnomad EAS exome
AF:
0.00256
Gnomad FIN exome
AF:
0.0644
Gnomad NFE exome
AF:
0.0913
Gnomad OTH exome
AF:
0.0869
GnomAD4 exome
AF:
0.0861
AC:
125798
AN:
1461668
Hom.:
5738
Cov.:
57
AF XY:
0.0862
AC XY:
62699
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.100
AC:
3352
AN:
33464
American (AMR)
AF:
0.0500
AC:
2232
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
3478
AN:
26132
East Asian (EAS)
AF:
0.00116
AC:
46
AN:
39694
South Asian (SAS)
AF:
0.0700
AC:
6037
AN:
86248
European-Finnish (FIN)
AF:
0.0666
AC:
3555
AN:
53406
Middle Eastern (MID)
AF:
0.128
AC:
739
AN:
5768
European-Non Finnish (NFE)
AF:
0.0909
AC:
101074
AN:
1111898
Other (OTH)
AF:
0.0875
AC:
5285
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
6575
13150
19724
26299
32874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3716
7432
11148
14864
18580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0874
AC:
13297
AN:
152154
Hom.:
603
Cov.:
30
AF XY:
0.0859
AC XY:
6385
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.100
AC:
4151
AN:
41506
American (AMR)
AF:
0.0706
AC:
1078
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
462
AN:
3460
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5184
South Asian (SAS)
AF:
0.0666
AC:
321
AN:
4820
European-Finnish (FIN)
AF:
0.0592
AC:
627
AN:
10594
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.0923
AC:
6279
AN:
67994
Other (OTH)
AF:
0.0851
AC:
180
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
613
1227
1840
2454
3067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0521
Hom.:
66
Bravo
AF:
0.0880
EpiCase
AF:
0.0946
EpiControl
AF:
0.0967

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.30
DANN
Benign
0.30
PhyloP100
-0.68
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41380244; hg19: chr11-102713447; COSMIC: COSV55406371; COSMIC: COSV55406371; API